Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
Roberto Gallego-Pinazo1,2, Ana Marina Suelves-Cogollos1, Ester Francés-Muñoz1, J María Millán2,3, J Fernando Arevalo4, J Luis Mullor5, Manuel Díaz-Llopis1,2,61Department of Ophthalmology, Hospital Universitario La Fe, Valenci...
Guardado en:
Autores principales: | Roberto Gallego-Pinazo, Ana Marina Suelves-Cogollos, Ester Francés-Muñoz, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce457d695cbe4dd0b47a38f5a27108df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011) -
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban AA, et al.
Publicado: (2012) -
Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
por: Yamashita M, et al.
Publicado: (2014) -
Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome
por: Luis Arias, et al.
Publicado: (2010) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017)